These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 19493409

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.
    Chok KS, Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST.
    Arch Surg; 2006 Dec; 141(12):1231-6. PubMed ID: 17178966
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 4. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN.
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [Abstract] [Full Text] [Related]

  • 5. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Hsu CY, Huang YH, Chiou YY, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee FY, Lee SD.
    Liver Transpl; 2011 May; 17(5):556-66. PubMed ID: 21506244
    [Abstract] [Full Text] [Related]

  • 11. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 12. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL, Ye SL, Zou JH, Ren ZG, Gan YH, Wang YH, Chen Y, Ge NL, Tang ZY, Yang BH.
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642
    [Abstract] [Full Text] [Related]

  • 15. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 16. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA.
    Ann Surg Oncol; 2005 Aug 01; 12(8):616-28. PubMed ID: 15965731
    [Abstract] [Full Text] [Related]

  • 17. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH, Choi MS, Choi YS, Kim DY, Lee JM, Paik SW, Lee JH, Koh KC, Yoo BC, Choi D, Rhee JC.
    Korean J Hepatol; 2006 Mar 01; 12(1):55-64. PubMed ID: 16565606
    [Abstract] [Full Text] [Related]

  • 18. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.
    Am Surg; 2008 Jul 01; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [Abstract] [Full Text] [Related]

  • 19. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J, Hinz S, Klomp HJ, Kapischke M, Kremer B.
    Eur J Surg Oncol; 2004 Jun 01; 30(5):551-5. PubMed ID: 15135485
    [Abstract] [Full Text] [Related]

  • 20. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
    Amersi FF, McElrath-Garza A, Ahmad A, Zogakis T, Allegra DP, Krasne R, Bilchik AJ.
    Arch Surg; 2006 Jun 01; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.